Literature DB >> 11265638

Disruption of the IL-1beta gene diminishes acetylcholine receptor-induced immune responses in a murine model of myasthenia gravis.

D Huang1, F D Shi, R Giscombe, Y Zhou, H G Ljunggren, A K Lefvert.   

Abstract

Human autoimmune myasthenia gravis (MG) is associated with the IL-1beta TaqI RFLP allele 2. Individuals positive for this allele have high levels of inducible IL-1beta in their peripheral blood. Here, we have characterized MG induction and the immune response elicited by Torpedo acetylcholine receptor (AChR) immunization in wild-type and IL-1beta deficient (-/-) mice. Compared with wild-type mice, IL-1beta-/- mice were relatively resistant to induction of clinical experimental autoimmune myasthenia gravis (EAMG). Draining lymph node cells from IL-1beta-/- mice showed poor proliferative capacity upon AChR stimulation in vitro. Both Th1 (IFN-gamma, IL-2) and Th2 (IL-4) cytokine responses were reduced and levels of serum anti-AChR antibodies decreased in IL-1beta-/- mice compared to wild-type mice. Taken together, these results reveal a critical role for IL-1beta in the induction of MG in mice, and support a role for IL-1beta in the pathogenesis of MG in man.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11265638     DOI: 10.1002/1521-4141(200101)31:1<225::AID-IMMU225>3.0.CO;2-0

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  4 in total

1.  Single-nucleotide polymorphisms in the B7H3 gene are not associated with human autoimmune myasthenia gravis.

Authors:  Priya Sakthivel; Xiongbiao Wang; Baback Gharizadeh; Ricardo Giscombe; Ritva Pirskanen; Pål Nyren; Ann Kari Lefvert
Journal:  J Genet       Date:  2006-12       Impact factor: 1.166

2.  Caspase-1 inhibitor ameliorates experimental autoimmune myasthenia gravis by innate dendric cell IL-1-IL-17 pathway.

Authors:  Cong-Cong Wang; Heng Li; Min Zhang; Xiao-Li Li; Long-Tao Yue; Peng Zhang; Yue Zhao; Shan Wang; Ruo-Nan Duan; Yan-Bin Li; Rui-Sheng Duan
Journal:  J Neuroinflammation       Date:  2015-06-14       Impact factor: 8.322

3.  A Natural Variant of the Signaling Molecule Vav1 Enhances Susceptibility to Myasthenia Gravis and Influences the T Cell Receptor Repertoire.

Authors:  Isabelle Bernard; Antoine Sacquin; Sahar Kassem; Mehdi Benamar; Céline Colacios; Mylène Gador; Corine Pérals; Nicolas Fazilleau; Abdelhadi Saoudi
Journal:  Front Immunol       Date:  2018-10-25       Impact factor: 7.561

Review 4.  New treatments for myasthenia: a focus on antisense oligonucleotides.

Authors:  Corrado Angelini; Sara Martignago; Michela Bisciglia
Journal:  Drug Des Devel Ther       Date:  2013-01-10       Impact factor: 4.162

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.